Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 904, Issue , 2012, Pages 93-98

  Nedić, Olgica ^a   LagundŽin, Dragana ^a   Masnikosa, Romana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Diabetes mellitus type 2; Fragmentation pattern; Glycation glycosylation; IGFBP 3; Ligand binding

Indexed keywords

DIABETES MELLITUS; FRAGMENTATION PATTERNS; GLYCATION; IGFBP-3; LIGAND BINDING;

AFFINITY CHROMATOGRAPHY; BINDING ENERGY; DEGRADATION; DESORPTION; GLYCOSYLATION; INSULIN; MASS SPECTROMETRY;

LIGANDS;

BORONIC ACID DERIVATIVE; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; LECTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ANALYTIC METHOD; ARTICLE; CANAVALIA; CANAVALIA ENSIFORMIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE COURSE; FEMALE; GLYCATION; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SAMBUCUS NIGRA; SIALYLATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BLOOD GLUCOSE; BLOTTING, WESTERN; BORONIC ACIDS; C-PEPTIDE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, AFFINITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LECTINS; MALE; N-ACETYLNEURAMINIC ACID; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; STATISTICS, NONPARAMETRIC;

CANAVALIA ENSIFORMIS; SAMBUCUS NIGRA;

EID: 84865384054     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.07.028     Document Type: Article

References (36)

1. Yatscoff R.W., Teavaarwerk G.J.M., MacDonald J.C. Clin. Chem. 1984, 30:446.
2. Daroux M., Prévost G., Maillard-Lefebvre H., Gaxatte C., D'Agati V.D., Schmidt A.M., Boulanger E. Diabetes Metab. 2010, 36:1.
3. Maritim A.C., Sanders R.A., Watkins J.B. J. Biochem. Mol. Toxicol. 2003, 17:24.
4. Davies M.J., Fu S., Wang H., Dean R.T. Free Radic. Biol. Med. 1999, 27:1151.
5. Guedes S., Vitorino R., Domingues M.R.M., Amado F., Domingues P. Anal. Bioanal. Chem. 2010, 397:1985.
6. Abdel-Wahab Y.H.A., O'Harte F.P.M., Barnett C.R., Flatt P.R. J. Endocrinol. 1997, 152:59.
7. O'Harte F.P.M., Boyd A.C., McKillop A.M., Abdel-Wahab Y.H.A., McNulty H., Barnett C.R., Conlon J.M., Hojrup P., Flatt P.R. Peptides 2000, 21:1519.
8. Lindsay J.R., McKillop A.M., Mooney M.H., Flatt P.R., Bell P.M., O'Harte F.P.M. Metabolism 2003, 52:631.
9. Cortizo A.M., Lee P.D.K., Cédola N.V., Jasper H., Gagliardino J.J. Acta Diabetol. 1998, 35:85.
10. Frystyk J. Growth Horm. IGF Res. 2004, 14:337.
11. Firth S.M., Baxter R.C. J. Endocrinol. 1999, 160:379.
12. Cortizo A.M., Gagliardino J.J. J. Endocrinol. 1995, 144:119.
13. Bang P., Brismar K., Rosenfeld R.G. J. Clin. Endocrinol. Metab. 1994, 78:1119.
14. Clemmons D.R., Sleevi M., Busby W.H. J. Clin. Endocrinol. Metab. 2005, 90:6561.
15. Binoux M., Lalou C., Mohseni-Zadeh S. The IGF System: Molecular Biology, Physiology and Clinical Applications 1999, 281. Humana Press, Totowa. R.G. Rosenfeld, C.T. Roberts (Eds.).
16. Sparbier K., Wenzel T., Kostrzewa M. J. Chromatogr. B 2006, 840:29.
17. Carlssona J., Gullstrandb C., Ludvigsson J., Lundström I., Winquist F. Talanta 2008, 76:333.
18. Colman P.G., Thomas D.W., Zimmet P.Z., Welborn T.A., Garcia-Webb P., Moore M.P. Med. J. Aust. 1999, 170:375.
19. Hunter W.M., Greenwood F.C. Nature 1962, 194:495.
20. Masnikosa R., Baričević I., LagundŽin D., Nedić O. Biochimie 2010, 92:97.
21. Nedić O., Masnikosa R. Clin. Exp. 2008, 57:658.
22. Yamada P.M., Mehta H.H., Hwang D., Roos K.P., Hevener A.L., Lee K.W. Endocrinology 2010, 151:5741.
23. Janssen J.A.M.J.L., Jacobs M.L., Derkx F.H.M., Weber R.F.A., Van der Lely A.J., Lamberts S.W.J. J. Clin. Endocrinol. Metab. 1997, 82:2809.
24. Capoluongo E., Pitocco D., Lulli P., Minucci A., Santonocito C., Manto A., Stasio E.D., Zaccardi F., Zuppi C., Ghirlanda G., Ameglio F. Cytokine 2006, 34:303.
25. Lassarre C., Duron F., Binoux M. J. Clin. Endocrinol. Metab. 2001, 86:1942.
26. Zandbergen A.A.M., Lamberts S.W.J., Baggen M.G.A., Janssen J.A.M.J.L., Boersma E., Bootsma A.H. Clin. Endocrinol. 2006, 64:203.
27. Diamandi A., Mistry J., Krishna R.G., Khosravi J. J. Clin. Endocrinol. Metab. 2000, 85:2327.
28. Stanley P. Cold Spring Harbor Perspect. Biol. 2011, 3:Review.
29. Aoyagi Y., Suzuki Y., Igarashi K., Saitoh A., Oguro M., Yokota T., Mori S., Suda T., Isemura M., Asakura H. Br. J. Cancer 1993, 67:486.
30. Gul A., Rahman M.A., Ahmed N. Opt. Appl. 2008, 38:531.
31. Manley S.E., Stratton I.M., Clark P.M., Luizo S.D. Clin. Chem. 2007, 53:922.
32. King E.R., Wong K-K. Patent Anti-Cancer Drug Disc. 2012, 7:14.
33. Baričević I., Masnikosa R., LagundŽin D., Golubović V., Nedić O. Clin. Biochem. 2010, 43:725.
34. Gallagher E.J., LeRoith D. Endocrinology 2011, 152:2546.
35. Shaw L.M. Cell Cycle 2011, 10:1750.
36. De Bock M., De Seny D., Meuwis M.A., Servais A.C., Minh T.Q., Closset J., Chapelle J.-P., Louis E., Malaise M., Merville M.-P., Fillet M. Talanta 2010, 82:245.